reference/22607805

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22607805

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	256
issn	0017-8748 1526-4610
issueIdentifier	3
pageRange	248-256
publicationName	Headache: The Journal of Head and Face Pain
startingPage	248
bibliographicCitation	Newman L, Mannix LK, Landy S, Silberstein S, Lipton RB, Putnam DG, Watson C, Jöbsis M, Batenhorst A, O'Quinn S. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache. 2001 Mar;41(3):248–56. doi: 10.1046/j.1526-4610.2001.111006248.x. PMID: 11264684.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e7545a301cfd8f50bbc3e70dc915803 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f191a04b766e56ed252f5499e720fb0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a218a7649ac2698cd0d5c77916aba10d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd7f7249aa6c63bec7e3d9b26d96c6cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cfd9dddca02aea99b49c8a27768b051 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6c697e74ded727f14a3aef4beaf5af9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b81410a66a203933da5182bb6a5208f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a692472238eee8adb53ff14b4c678d23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_479f4b8f35fef2afeef09e7bd94ad843 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4f9e8dc5807e85e371bd6ae78c72103
date	2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1046/j.1526-4610.2001.111006248.x https://pubmed.ncbi.nlm.nih.gov/11264684
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3966 https://portal.issn.org/resource/ISSN/1526-4610 https://portal.issn.org/resource/ISSN/0017-8748
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Naratriptan as Short‐Term Prophylaxis of Menstrually Associated Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study
discusses	http://id.nlm.nih.gov/mesh/M0016885 http://id.nlm.nih.gov/mesh/M0278097 http://id.nlm.nih.gov/mesh/M0011238 http://id.nlm.nih.gov/mesh/M0022087 http://id.nlm.nih.gov/mesh/M0026371
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017366Q000627 http://id.nlm.nih.gov/mesh/D008881Q000517 http://id.nlm.nih.gov/mesh/D010880Q000627 http://id.nlm.nih.gov/mesh/D008598 http://id.nlm.nih.gov/mesh/D007211Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008881Q000209 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D014363 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8494 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4440 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5358

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128419875 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127427940

Total number of triples: 54.